IT1402654B1 - Composizione per il rilascio di principi attivi da dispositivi di impianto - Google Patents

Composizione per il rilascio di principi attivi da dispositivi di impianto

Info

Publication number
IT1402654B1
IT1402654B1 ITTO2010A000766A ITTO20100766A IT1402654B1 IT 1402654 B1 IT1402654 B1 IT 1402654B1 IT TO2010A000766 A ITTO2010A000766 A IT TO2010A000766A IT TO20100766 A ITTO20100766 A IT TO20100766A IT 1402654 B1 IT1402654 B1 IT 1402654B1
Authority
IT
Italy
Prior art keywords
release
composition
active principles
plant devices
plant
Prior art date
Application number
ITTO2010A000766A
Other languages
English (en)
Inventor
Maria Curcio
Andrea Grignani
Ilaria Zambaldi
Daniela Gramaglia
Original Assignee
Cid S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cid S R L filed Critical Cid S R L
Priority to ITTO2010A000766A priority Critical patent/IT1402654B1/it
Priority to ES11785091.7T priority patent/ES2614481T3/es
Priority to EP11785091.7A priority patent/EP2618859B1/en
Priority to CN201180045104.9A priority patent/CN103118716B/zh
Priority to US13/825,074 priority patent/US9011898B2/en
Priority to PCT/IB2011/054092 priority patent/WO2012038881A1/en
Publication of ITTO20100766A1 publication Critical patent/ITTO20100766A1/it
Application granted granted Critical
Publication of IT1402654B1 publication Critical patent/IT1402654B1/it
Priority to HK13113002.4A priority patent/HK1185573A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/426—Immunomodulating agents, i.e. cytokines, interleukins, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ITTO2010A000766A 2010-09-20 2010-09-20 Composizione per il rilascio di principi attivi da dispositivi di impianto IT1402654B1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ITTO2010A000766A IT1402654B1 (it) 2010-09-20 2010-09-20 Composizione per il rilascio di principi attivi da dispositivi di impianto
ES11785091.7T ES2614481T3 (es) 2010-09-20 2011-09-19 Composición para la administración de principios activos mediante dispositivos de implante
EP11785091.7A EP2618859B1 (en) 2010-09-20 2011-09-19 Composition for active principles delivery by implant devices
CN201180045104.9A CN103118716B (zh) 2010-09-20 2011-09-19 用于通过植入装置递送活性成分的组合物
US13/825,074 US9011898B2 (en) 2010-09-20 2011-09-19 Composition for active principles delivery containing a fatty acid excipient
PCT/IB2011/054092 WO2012038881A1 (en) 2010-09-20 2011-09-19 Composition for active principles delivery by implant devices
HK13113002.4A HK1185573A1 (zh) 2010-09-20 2013-11-21 用於通過植入裝置遞送活性成分的組合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITTO2010A000766A IT1402654B1 (it) 2010-09-20 2010-09-20 Composizione per il rilascio di principi attivi da dispositivi di impianto

Publications (2)

Publication Number Publication Date
ITTO20100766A1 ITTO20100766A1 (it) 2012-03-21
IT1402654B1 true IT1402654B1 (it) 2013-09-13

Family

ID=43720863

Family Applications (1)

Application Number Title Priority Date Filing Date
ITTO2010A000766A IT1402654B1 (it) 2010-09-20 2010-09-20 Composizione per il rilascio di principi attivi da dispositivi di impianto

Country Status (7)

Country Link
US (1) US9011898B2 (it)
EP (1) EP2618859B1 (it)
CN (1) CN103118716B (it)
ES (1) ES2614481T3 (it)
HK (1) HK1185573A1 (it)
IT (1) IT1402654B1 (it)
WO (1) WO2012038881A1 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014182542A1 (en) * 2013-05-06 2014-11-13 Abbott Cardiovascular Systems Inc. A hollow stent filled with a therapeutic agent formulation
DE102013110294B4 (de) 2013-09-18 2016-07-07 Innora Gmbh Limus-Depot-Formulierung auf Ballonkathetern
ITUA20162092A1 (it) * 2016-03-29 2017-09-29 Cid S P A Perfezionamenti negli stent per il rilascio di principi attivi
ITUA20162094A1 (it) * 2016-03-29 2017-09-29 Cid S P A Perfezionamenti negli stent per il rilascio di principi attivi
ITUA20162087A1 (it) * 2016-03-29 2017-09-29 Cid S P A Perfezionamenti negli stent per il rilascio di principi attivi
CA3034676A1 (en) * 2016-06-24 2017-12-28 W. L. Gore & Associates, Inc. Drug coated balloons and techniques for increasing vascular permeability

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR012448A1 (es) 1997-04-18 2000-10-18 Ipsen Pharma Biotech Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
US20030077310A1 (en) * 2001-10-22 2003-04-24 Chandrashekhar Pathak Stent coatings containing HMG-CoA reductase inhibitors
US8124127B2 (en) * 2005-10-15 2012-02-28 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US7628807B2 (en) * 2004-11-04 2009-12-08 Boston Scientific Scimed, Inc. Stent for delivering a therapeutic agent having increased body tissue contact surface
ITTO20070356A1 (it) * 2007-05-21 2008-11-22 Sorin Biomedica Cardio Srl "composizione per il rilascio di principi attivi da dispositivi di impianto"

Also Published As

Publication number Publication date
ITTO20100766A1 (it) 2012-03-21
EP2618859B1 (en) 2016-11-09
CN103118716B (zh) 2016-02-24
WO2012038881A1 (en) 2012-03-29
EP2618859A1 (en) 2013-07-31
ES2614481T3 (es) 2017-05-31
HK1185573A1 (zh) 2014-02-21
US20130280315A1 (en) 2013-10-24
US9011898B2 (en) 2015-04-21
CN103118716A (zh) 2013-05-22

Similar Documents

Publication Publication Date Title
SMT201600326B (it) Distribuzione respiratoria di principi attivi
SMT201600350B (it) Composizioni farmaceutiche
SMT201700008B (it) Composizione farmaceutica
SMT201600049B (it) Formulazioni di apixaban
DK2640893T4 (da) Sammensætninger
BR112013014986A2 (pt) compostos inseticidas
DK2613819T4 (da) Smørende belægninger til medicinske anordninger
DK3246018T3 (da) Farmaceutisk sammensætning
GT201200303A (es) Formulaciones farmacéuticas
EE201300005A (et) Ravimkoostis
CO6801722A2 (es) Composiciones farmacéuticas
IT1402654B1 (it) Composizione per il rilascio di principi attivi da dispositivi di impianto
SMT201200040B (it) Composizioni di flupentixol
FR2965705B1 (fr) Compositions d'edulcorants
EP2780051A4 (en) NEW IMPROVED FORMULATIONS FOR COATING MEDICAL DEVICES
BR112013007469A2 (pt) composições farmacêuticas antidiabéticas sólidas
IL226554A (en) Medicinal preparations containing alisporiovir
HK1162959A1 (en) Pharmaceutical compositions comprising dronedarone
BR112012029461A2 (pt) composição farmacêutica contendo solifenacina
GB201206972D0 (en) Coating composition for plant structures
DK2394638T3 (da) Nye farmaceutiske sammensætninger
FI20105066A0 (fi) Kasvin kasvusuoja
DK2598175T3 (da) Radiofarmaceutiske sammensætninger
ZA201209038B (en) Adhesive slow-release formulations for the local administration of curcumin
BR112012029887A2 (pt) composição farmacêutica